Overview

Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure

Status:
Terminated
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Nivolumab is effective in the treatment of radiation-induced solid tumors.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborator:
Bristol-Myers Squibb
Treatments:
Antibodies, Monoclonal
Nivolumab